ChEMBL

If you're working in drug discovery, chemical biology, or just curious about how small molecules interact with biological systems, ChEMBL is the kind of resource you'll want bookmarked. It's not a commercial product or a flashy app; it's a massive, meticulously curated database from the European Bioinformatics Institute (EMBL-EBI) that brings together an enormous collection of data on bioactive molecules with drug-like properties. Think of it as a central hub where chemical structures, their measured biological activities against specific targets, and related genomic information all meet in one place. The whole point is to help researchers translate genomic information into actual, effective new drugs by providing the hard data needed to understand molecular interactions. Let's dive into what's actually inside. ChEMBL is packed with a staggering amount of information. At its core are nearly 3 million distinct compounds (specifically, 2,921,148 as of the latest release), each with a defined chemical structure. These aren't just random chemicals; they are selected for their relevance to drug discovery. For each of these compounds, the database provides detailed "bioactivity" data. This data comes from over 24.5 million activity records extracted and curated from hundreds of thousands of scientific publications and deposited datasets. So, you can look up a specific compound, like the cancer drug Imatinib, and see not just its structure, but also a wealth of data on how it performs in various biological assays—what its concentration is that produces an effect, which cell lines or tissues it was tested on, and the results from those experiments. Beyond just compounds and activities, ChEMBL is rich with contextual data that makes it incredibly powerful for connecting the dots